The ERK-RSK1 activation by growth factors at G2 phase delays cell cycle progression and reduces mitotic aberrations

Hyun-Ja Nam1, Sujeong Kim, Min-Woo Lee

  • 1Department of Biochemistry and Molecular Biology, Ajou University School of Medicine, South Korea.

Insights

Growth factors like HGF can delay the G2/M cell cycle transition, mediated by ERK-RSK1 signaling. This delay may be crucial for maintaining genomic integrity during growth factor stimulation.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Research

Background:

  • Growth factors typically accelerate cell cycle progression from G0 to S phase.
  • The specific roles of growth factors in other cell cycle phases, particularly G2/M, remain largely unexplored.

Purpose of the Study:

  • To investigate the impact of growth factors, specifically hepatocyte growth factor (HGF), on the G2/M transition in HeLa cells.
  • To elucidate the molecular mechanisms underlying HGF-induced G2/M delay and its potential role in maintaining genomic stability.

Main Methods:

  • HeLa cells were treated with HGF, epidermal growth factor (EGF), and fibroblast growth factor (FGF).
  • Cell cycle progression was analyzed using Fluorescence-Activated Cell Sorting (FACS), mitotic index counts, and time-lapse microscopy.
  • Key molecular players including cyclin B1, MAPK kinase (MEK), ribosomal S6 kinase (RSK), and extracellular-regulated protein kinase (ERK) were assessed.
  • RNA interference (siRNA) was used to knockdown RSK1 and RSK2.
  • Chromosomal segregation and aberrations were analyzed.

Main Results:

  • HGF treatment at G2 phase induced a delay in G2/M transition, a phenomenon also observed with EGF and FGF.
  • HGF treatment delayed cyclin B1-associated kinase activation and diminished its nuclear translocation.
  • The G2/M delay was abolished by a MEK inhibitor (U0126) or a kinase-dead RSK mutant.
  • Knockdown of RSK1, but not RSK2, abrogated the HGF-induced G2/M delay, implicating the ERK-RSK1 pathway.
  • Cells expressing an oncogenic HGF receptor showed abolished G2/M delay upon RSK1 knockdown.
  • HGF induced chromosomal segregation defects, which were exacerbated by RSK1 depletion.

Conclusions:

  • Growth factor stimulation, via the ERK-RSK1 pathway, can delay G2/M cell cycle transition.
  • This delay appears to be a protective mechanism to maintain genomic integrity during active growth factor signaling.
  • The findings highlight a novel role for growth factors in regulating cell cycle checkpoints beyond the G0/S transition.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.